GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DXCM · Dec 31, 2019

DEXCOM INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001093557-20-000029General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

12.20% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

21.31% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

43.08% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

8.12% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

63.11% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

9.64% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

18.53% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

6.96% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History21 statesSelf-history eligible
Mar 31, 20190/7 normalizedLevel 3Jun 30, 20190/7 normalizedLevel 3Sep 30, 20190/7 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/8 normalizedLevel 3Jun 30, 20200/8 normalizedLevel 3Sep 30, 20200/8 normalizedLevel 3Dec 31, 20207/8 normalizedLevel 3Mar 31, 20217/8 normalizedLevel 3Jun 30, 20217/8 normalizedLevel 3Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Sep 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
12.54%
Current
12.20%
Delta
-0.35%
Cash Generation Decreased
Previous
23.85%
Current
21.31%
Delta
-2.54%
Inventory Pressure Decreased
Previous
30.38%
Current
8.12%
Delta
-22.26%
Margin Increased
Previous
62.30%
Current
63.11%
Delta
0.81%
Profitability Decreased
Previous
14.13%
Current
9.64%
Delta
-4.49%
R And D Intensity Increased
Previous
16.83%
Current
18.53%
Delta
1.70%
Sbc Intensity Increased
Previous
6.16%
Current
6.96%
Delta
0.80%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DXCM Fundamental State →Has State · DEXCOM INC →Transitioned To · DXCM Fundamental State →Transitioned To · DXCM CAPEX_INTENSITY_DECREASED →Transitioned To · DXCM CASH_GENERATION_DECREASED →Transitioned To · DXCM INVENTORY_PRESSURE_DECREASED →Transitioned To · DXCM MARGIN_INCREASED →Transitioned To · DXCM PROFITABILITY_DECREASED →Transitioned To · DXCM R_AND_D_INTENSITY_INCREASED →Transitioned To · DXCM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.